U.S. stock futures were flat in early morning trading on Wednesday ahead of the first batch of corporate earnings.
Dow futures traded just 16 points higher. S&P 500 futures and Nasdaq 100 futures both hovered in mildly positive territory.
On Tuesday, the S&P 500 climbed 0.4% to close at a record high. Equities shrugged off the Food and Drug Administration’s request for states to pause administering Johnson & Johnson’s Covid-19 vaccine after six people in the U.S. developed a rare disorder involving blood clots. Moderna shares gained more than 7% on the news.
After the bell on Tuesday, Pfizer CEO Albert Bourla said the drugmaker can deliver 10% more vaccine doses to the U.S. by the end of…